dose.io Smart medication dispenser with cloud-based platform for collecting and analyzing data on adherence to therapy.

getdose.io // hello@getdose.io

2. Death of 200k patients annually

1. Non-adherence to therapy

3. Pharmaceutical companies lose revenue, $137.5B annually

Problem Approximately 50% of people do not take drugs as prescribed. According to World Health Organization.

1/20

5. Insurance companies isn’t protected f rom people who don’t adhere to the prescribed rules for taking medications

4. The state suffers additional healthcare costs due to low adherence

Adherence Drop-Off

01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22MONTHS

AD

HER

ENC

E

0%

10%20%

30%40%

50%60%70%80%90%

100% СLUSTER 1

СLUSTER 2

СLUSTER 3

ONCOLOGY - BREASTDIABETSCARDIOVASCULAR - HYPRETENSIONCARDIOVASCULAR - STATIN

GASTROINTESTINAL - PPIONCOLOGY - PROSTATENEUROSCIENCE - ANTI PSYCHOTIC

RESPIRATORY - ASTHMA INHALED CSRESPIRATORY - ASTHMA BRONCHODILATOR

2/20

Problem

Kidney 

Oncological  

Blood  

Organ transplant patients 

Endocrine 

The occurrence of relapses 

Hospitalization 

The increase in treatment costs

A significant role in the treatment of patients is played by their adherence to prescribed therapy.  Regardless of the medication, it’s important to follow the systematic reception, follow the doctor’s recommendations, otherwise it can very often lead to disastrous consequences. For example: one missed dose can increase drug resistance, which will complicate further treatment.

What is the result of non-adherence to therapy?  Disease area: 

Switching to other medications or adding new ones

3/20

What is Resistance?

INCREASED RISK OF SIDE EFFECTS

INCREASED RISK OF RESISTANCE

DR

UG

LEV

ELS

DOSEDOSE DOSE DOSE

Minimum level

Taking meds on time

INCREASED RISK OF SIDE EFFECTS

INCREASED RISK OF RESISTANCE

Missed doseDOSE

Missing a dose or taking it late

TIME4/20

Сonfirmation of problem

Capgemini Consulting — Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence https://www.capgemini.com/wp-content/uploads/2017/07/Estimated_Annual_Pharmaceutical_Revenue _Loss_Due_to_Medication_Non-Adherence.pdf

S3 Connected Health — How The Pharma Industry Is Tackling Medication Adherence https://www.s3group.com/wp-content/uploads/sites/4/2015/06/Medication-Adherence-Pharma-Survey.pdf

Bayer — Medication Adherence http://pharma.bayer.com/en/commitment-responsibility/benefits-and-risks-of-drugs/medication-adherence/

Articles and studies:

1

2

3

5/20

SolutionThe device that replaces the usual cap and keeps track of medication, reminds to reception, sends notifications to smartphone.

Doctors

Profits for:Patients Pharma

Reduced drug costs

Improving the quality of therapy

A flexible tool for interacting with a doctor

Ability to prolong medication

Permanent Observation ProgramDepersonalized global statisticsA strong tool for making both marketing and strategic

Convenient and effective way to interact with the patient

6/20

Government

Insurance companies

Reducing healthcare costsA tool to counteract socially significant diseases

Risk Hedging

ProductSmart dispenser

Smartphone app (iOS/Android)

SaaS/DaaS for pharmacy and clinics

7/20

Technology

Cloud

Patient

Doctor

Key feature: device transmits data directly to the server, bypassing any devices, which allows to configure and monitor patient prof iles in realtime. This greatly simplifies the user experience of dose.io, it's very important for senior citizens.

8/20

MarketSmart and IoT healthcare

2017

CAGR 30.2%Development of technologies and improvement of technological processes allows to reduce the final cost of production

$ 56.1 B

$ 267.6 B

According to a P&S Intelligence

Growing number of patients

2023

New laws on telemedicine 9/20

Market

$133B TAM$33B SAM $12.5M SOM Market type:

10/20

Target markets:US&EU

b2b2c

Competitors

All existing solutions for transmitting the data need to be connected to intermediate devices and doesn’t account for dose and residue

RoundReffill

$39.99+

11/20

Competitive Advantages

Lower CostCompactness and autonomy

Independence Dose and residue accounting

Design and better UX

Various modifications

$

12/20

Business ModelProblem Solution

Key Metrics

Cost Structure Revenue Streams

Channels

Unique Value Proposition

Unfair Advantages

Customer Segments

Early Adopters

Experience with overdose and death Pharmaceutical companies lose revenue Low treatment efficiency

Marketing Certification Device manufacturing Infrastructure Salary fund

Smart pill dispenser for medication and cloud platform for data analysis and

Increase adherence Cost reduction for patients CAC/LTV (b2b)

DaaS and analytics Device sale SaaS

Biohackers

New laws on telemedicine

Online sales Pharmacies Clinics

Low cost No need for other connections Track residue of medications Compactness and autonomy

Chronic patients People who like BAA People in critical conditions

13/20

Market Adoption

Partnerships wiсh pharma

SaaS platform development

DaaS platform development

Scaling technology to other solutions

14/20

UPTO

DATE

Traction

We have a commit to collaboration with SH - Pharma

Prototype developed

We started!

Jule

August

January 15/20

We’re negotiating with pharma companies

about pilot launch

Team

Egor Gargolin CEO Managed projects with Micron. Studying for a BSc MIET.

Kirill Frolov СPO 3 years of experience in product management and development. Studying for a BSc BMSTU.

Vladimir Bogdanov CTO 3 years in the development of IoT devices. Hardware engineer in NVP Bolid. BSc MIET.

Anton Pchelkin Fullstack Developer 8 years in development. Team Lead at Moqod. CTO Fabinka. ex Software Engineer at Algont.

16/20

Mentors

Pavel Bilenko BD Advisor Head of Industry 4.0 Educational Programmes at Moscow School of Management SKOLKOVO. CEO Tekner.

Igor Shaderkin Medical Advisor Head of Electronic Health Laboratory, Institute of Digital Medicine FMSMU (Sechenov University).

17/20

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi

hi hi

hi

hi

hi

hi

hi

hi

Contacts

Egor Gargolin +7 905 727 06 98  facebook.com/bariors  bariors98@gmail.com

Kirill Frolov+7 926 160 98 63  facebook.com/m2750g  kirill.nik25@gmail.com

egor-gargolin kirill-frolov

20/20

getdose.io // hello@getdose.io